Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

January 1, 2032

Study Completion Date

January 1, 2032

Conditions
Mild Cognitive ImpairmentSubjective Cognitive Decline
Interventions
BEHAVIORAL

Assessments

Participants will undergo a standard battery of neuropsychological measures, behavioral questionnaire, and functional assessment to monitor cognition and function over time. Clinical data obtained as part of standard of care will be collected from the medical record

OTHER

Neuroimaging volumetric measures

Neuroimaging volumetric measures will be obtained from already conducted standard of care neuroimaging.

OTHER

Biofluid samples

Biofluid sampling data will be obtained through another protocol. All participants will be required to sign that consent to participate in this trial.

Trial Locations (1)

43210

The Ohio State University, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT06542458 - Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog | Biotech Hunter | Biotech Hunter